The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Share News (BOY)

Share Price Information for Bodycote (BOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 738.00
Bid: 731.00
Ask: 733.00
Change: 2.00 (0.27%)
Spread: 2.00 (0.274%)
Open: 737.00
High: 738.00
Low: 731.00
Prev. Close: 736.00
BOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bodycote chooses industry veteran Jim Fairbairn as new CEO

Wed, 18th Oct 2023 07:08

(Sharecast News) - Bodycote has chosen a veteran of the engineering sector to run the company starting from early 2024.

The supplier of heat treatments, metal joining, hot isostatic pressing and coatings services, has chosen Jim Fairbairn as its next chief executive officer.

Fairbairn had three decades of experience in the sector, including at John Wood Group, Clyde Bergemann, Howden Group and Megger Group, where he held the role of divisional chief executive officer and then group CEO.

Bodycote's current chief, Stephen Harris, said: "I am confident Jim has the right skills and experience to continue to drive the Company's strategy and performance over the coming years.

"In the meantime, I remain focused on the initiatives we have in place to develop and solidify Bodycote's leadership position in its chosen markets."

At Megger Group, Fairbairn had overseen "material" growth in sales to reach £325m since joining in 2017.

Fairbairn was scheduled to join Bodycote's board in March 2024 and to assume his new post on 31 May of the same year.

More News
16 Mar 2021 09:39

BROKER RATINGS: CS upgrades HSBC, Barclays and NatWest, cuts StanChart

BROKER RATINGS: CS upgrades HSBC, Barclays and NatWest, cuts StanChart

Read more
12 Mar 2021 08:32

TOP NEWS: Bodycote outlook confident despite swing to loss in 2020

TOP NEWS: Bodycote outlook confident despite swing to loss in 2020

Read more
12 Mar 2021 07:36

Bodycote revenues, profits fall as it repositions business

(Sharecast News) - Bodycote's revenues fell 16.9% in 2020 to £598m, it said on Friday, as its organic revenues declined 20%.

Read more
5 Mar 2021 15:56

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
9 Feb 2021 13:46

Tuesday broker round-up

(Sharecast News) - Spirent Communications: Canaccord upgrades to buy with a target price of 275p.

Read more
9 Feb 2021 09:31

BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut

BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut

Read more
5 Feb 2021 15:57

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
20 Jan 2021 09:40

LONDON BROKER RATINGS SUMMARY: BofA And Jefferies Both Cut John Wood

LONDON BROKER RATINGS SUMMARY: BofA And Jefferies Both Cut John Wood

Read more
18 Jan 2021 09:34

UK BROKER RATINGS SUMMARY: Land Securities And Dixons Get Upgrades

UK BROKER RATINGS SUMMARY: Land Securities And Dixons Get Upgrades

Read more
15 Jan 2021 09:38

UK BROKER RATINGS SUMMARY: JPMorgan Raises Derwent, Cuts Shaftesbury

UK BROKER RATINGS SUMMARY: JPMorgan Raises Derwent, Cuts Shaftesbury

Read more
31 Dec 2020 17:12

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
9 Dec 2020 09:50

UK BROKER RATINGS SUMMARY: Citi Upgrades National Grid And 3i Group

UK BROKER RATINGS SUMMARY: Citi Upgrades National Grid And 3i Group

Read more
3 Dec 2020 09:34

UK BROKER RATINGS SUMMARY: Bernstein Boosts Shell To Outperform

UK BROKER RATINGS SUMMARY: Bernstein Boosts Shell To Outperform

Read more
30 Nov 2020 13:40

Monday broker round-up

(Sharecast News) - Bodycote: JP Morgan downgrades to underweight with a target price of 635p.

Read more
30 Nov 2020 09:49

UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral

UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.